Clinical Trial Update: Safety and Efficacy of ES-NK Cell Injection in the Treatment of Refractory Lupus Nephritis: an Early Clinical Study [EARLY_Phase 1]

View source ↗

Summary

Early Phase 1 clinical trial assessing the safety and potential efficacy of ES-NK cell injections for refractory lupus nephritis; the study is not yet recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lupus Nephritis
• Systemic Lupus Erythematosus

Drugs mentioned

• ES-NK cell injection (ES-NK cell)

Snippet

Sponsor: Shanghai Jiao Tong University School of Medicine | Conditions: Systemic Lupus Erythenlatosus Nephritis | EARLY_Phase 1 | Status: NOT_YET_RECRUITING